Fust Matthew K - Insider Non-Derivative Transactions at Ultragenyx Pharmaceutical Inc. (RARE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 18, 2024, Fust Matthew K's relationship to Ultragenyx Pharmaceutical Inc. (RARE) is Director, and currently has 20,205 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RARE insiders.

Data Source: SEC.
Fust Matthew K - Insider Non-Derivative Transactions of RARE Common Stock
Jul 01Oct 01Jan 01Apr 0105K10K15K20K25K30K35K
Fust Matthew K - Insider Non-Derivative Transactions at RARE
Date
Transaction
No. of Shares
Price Per Share
Shares Owned After Transactions
Jun 19, 2024 Acquisition -- (Common Stock) 5,345 0 20,205
Mar 8, 2024 Sell -- (Common Stock) 7,500 50.88 14,860
Mar 8, 2024 Sell -- (Common Stock) 2,145 50.85 22,360
Mar 8, 2024 Sell -- (Common Stock) 2,550 50.89 24,505
Jun 8, 2023 Disposition -- (Common Stock) 3,300 51.82 27,055
Jun 8, 2023 Acquisition -- (Common Stock) 3,860 0 30,355
Items per page:
1 – 6 of 6